[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR9007016A - PROCESS FOR TREATING PATIENTS, PROCESS FOR THE PRODUCTION OF VACCINE AGAINST HIV RETROVIRUS INFECTION, PROCESS FOR TREATING INFECTED PATIENTS, PROCESS FOR TREATING AIDS PATIENTS, PROCESS FOR INCREASING THE NUMBER OF NON-INFECTED CELLS IN A PATIENT, TREATMENT OF PATIENTS WITH HIV RETROVIRUS INFECTION, PHOTO COMPOUND, APPARATUS AND PHOTOPHERESIS - Google Patents

PROCESS FOR TREATING PATIENTS, PROCESS FOR THE PRODUCTION OF VACCINE AGAINST HIV RETROVIRUS INFECTION, PROCESS FOR TREATING INFECTED PATIENTS, PROCESS FOR TREATING AIDS PATIENTS, PROCESS FOR INCREASING THE NUMBER OF NON-INFECTED CELLS IN A PATIENT, TREATMENT OF PATIENTS WITH HIV RETROVIRUS INFECTION, PHOTO COMPOUND, APPARATUS AND PHOTOPHERESIS

Info

Publication number
BR9007016A
BR9007016A BR909007016A BR9007016A BR9007016A BR 9007016 A BR9007016 A BR 9007016A BR 909007016 A BR909007016 A BR 909007016A BR 9007016 A BR9007016 A BR 9007016A BR 9007016 A BR9007016 A BR 9007016A
Authority
BR
Brazil
Prior art keywords
patients
treating
retrovirus infection
hiv retrovirus
infected
Prior art date
Application number
BR909007016A
Other languages
Portuguese (pt)
Inventor
Albert S Klainer
Emil Bisaccia
Original Assignee
Albert S Klainer
Emil Bisaccia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/295,454 external-priority patent/US4960408A/en
Application filed by Albert S Klainer, Emil Bisaccia filed Critical Albert S Klainer
Publication of BR9007016A publication Critical patent/BR9007016A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0066—Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR909007016A 1989-01-10 1990-01-10 PROCESS FOR TREATING PATIENTS, PROCESS FOR THE PRODUCTION OF VACCINE AGAINST HIV RETROVIRUS INFECTION, PROCESS FOR TREATING INFECTED PATIENTS, PROCESS FOR TREATING AIDS PATIENTS, PROCESS FOR INCREASING THE NUMBER OF NON-INFECTED CELLS IN A PATIENT, TREATMENT OF PATIENTS WITH HIV RETROVIRUS INFECTION, PHOTO COMPOUND, APPARATUS AND PHOTOPHERESIS BR9007016A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/295,454 US4960408A (en) 1989-01-10 1989-01-10 Treatment methods and vaccines for stimulating an immunological response against retroviruses
US36406389A 1989-06-08 1989-06-08
US46081190A 1990-01-04 1990-01-04

Publications (1)

Publication Number Publication Date
BR9007016A true BR9007016A (en) 1991-11-12

Family

ID=27404363

Family Applications (1)

Application Number Title Priority Date Filing Date
BR909007016A BR9007016A (en) 1989-01-10 1990-01-10 PROCESS FOR TREATING PATIENTS, PROCESS FOR THE PRODUCTION OF VACCINE AGAINST HIV RETROVIRUS INFECTION, PROCESS FOR TREATING INFECTED PATIENTS, PROCESS FOR TREATING AIDS PATIENTS, PROCESS FOR INCREASING THE NUMBER OF NON-INFECTED CELLS IN A PATIENT, TREATMENT OF PATIENTS WITH HIV RETROVIRUS INFECTION, PHOTO COMPOUND, APPARATUS AND PHOTOPHERESIS

Country Status (9)

Country Link
EP (1) EP0453497A4 (en)
JP (1) JPH04502621A (en)
AU (1) AU638693B2 (en)
BR (1) BR9007016A (en)
CA (1) CA2007499C (en)
FI (1) FI105453B (en)
HU (1) HUT62487A (en)
IL (1) IL92996A (en)
WO (1) WO1990007952A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US6433343B1 (en) 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
FR2694886A1 (en) * 1992-08-06 1994-02-25 Zaki George Extracorporeal blood sterilisation - with combination of UV irradiation and sterilising gas, used for treating blood from patients with bacterial, parasitic, or viral infection.
FR2698270B1 (en) * 1992-11-20 1995-01-13 Goupil Jean Jacques Use of 5-methoxypsoralen in the treatment of AIDS.
ES2201093T3 (en) * 1993-11-10 2004-03-16 Cerus Corporation DEVICE AND PROCEDURE FOR PHOTOACTIVATION.
WO1996008965A1 (en) * 1994-09-22 1996-03-28 Baxter International, Inc. Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
DE19914850A1 (en) * 1999-04-01 2000-10-05 Gerhard Saalmann Device for inactivating viruses, especially human immunodeficiency virus (HIV) from blood products, uses coloring agents and radiation
EP1465699A4 (en) * 2001-12-12 2006-05-24 Leon J Lewandowski Photophoretic auto immune stimulation
AU2004224425B2 (en) * 2003-02-06 2010-06-24 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
US20080102505A1 (en) * 2006-09-18 2008-05-01 Petrie Thomas R Jr Method of treating viral infections with ultraviolet light
GB2509940A (en) * 2013-01-18 2014-07-23 John Ogino Vaccine production via irradiation of pathogenic cultures

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4568542A (en) * 1981-06-09 1986-02-04 Lee Biomolecular Research Laboratories, Inc. Vaccine compositions
US4464166A (en) * 1981-06-12 1984-08-07 Frederic A. Bourke, Jr. Method for externally treating the blood
EP0124363B1 (en) * 1983-05-02 1990-12-19 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
DK507185A (en) * 1984-11-05 1986-05-06 Du Pont METHOD OF INACTIVATING HUMAN TUMOR LEUKAEMI VIRUS III
US4838852A (en) * 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression

Also Published As

Publication number Publication date
CA2007499A1 (en) 1990-07-10
FI105453B (en) 2000-08-31
IL92996A (en) 1996-06-18
HUT62487A (en) 1993-05-28
AU638693B2 (en) 1993-07-08
EP0453497A1 (en) 1991-10-30
AU4954590A (en) 1990-08-13
FI913318A0 (en) 1991-07-09
CA2007499C (en) 2001-03-27
JPH04502621A (en) 1992-05-14
WO1990007952A1 (en) 1990-07-26
EP0453497A4 (en) 1992-10-07

Similar Documents

Publication Publication Date Title
BR8804823A (en) PHARMACEUTICAL COMPOSITION, PROCESS FOR HIV TREATMENT AND PREVENTION OF HIV INFECTION IN A HUMAN BEING AND PROCESS FOR COMPOSITION PRODUCTION
BR9007016A (en) PROCESS FOR TREATING PATIENTS, PROCESS FOR THE PRODUCTION OF VACCINE AGAINST HIV RETROVIRUS INFECTION, PROCESS FOR TREATING INFECTED PATIENTS, PROCESS FOR TREATING AIDS PATIENTS, PROCESS FOR INCREASING THE NUMBER OF NON-INFECTED CELLS IN A PATIENT, TREATMENT OF PATIENTS WITH HIV RETROVIRUS INFECTION, PHOTO COMPOUND, APPARATUS AND PHOTOPHERESIS
NO922936D0 (en) PREPARATION OF FATIC ACID MEDICINES
CA2072573A1 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
Reif et al. Epizootic vesicular stomatitis in Colorado, 1982: infection in occupational risk groups
PT88930A (en) METHOD FOR THE PREPARATION OF NEW ANALYSES OF NUCLEOSIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MX9203543A (en) MEDICINE.
WO1996006620A3 (en) Lipid analogs for treating viral infections
PL297849A1 (en) Vaccine against and method of treating the patients infectedwith hiv virus
DK92788A (en) USE OF 3'-DEOXY-3'-FLUORUANOSIDES FOR THE PREPARATION OF MEDICINAL PRODUCTS AGAINST RETROVIRA
ES2038650T3 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION INCLUDING 3'-DEOXYTIMIDIN-2'-ENO- (3'-DESOXI-2 ', 3'-DIDESHIDROTIMIDINA) TO TREAT PATIENTS INFECTED WITH RETROVIRUS.
PT97621A (en) PROCESS FOR THE PREPARATION OF VACCINES AGAINST HUMAN PAPILOMAVIRUS 18 (HPV 18)
ZA968783B (en) Flupirtine usage
GR3014952T3 (en) Use of an immunoglobulin-containing composition in the prophylaxis and therapy of AIDS of human.
DK56389A (en) PREVENTION AND TREATMENT OF RETROVIRAL DISEASES
ES2162862T3 (en) USE OF TIMOSINE TO TREAT HEPATITIS C IN PATIENTS WHO DO NOT RESPOND TO THE INTERFER TREATMENT.
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
BR9007904A (en) PROCESS AND COMPOSITION FOR THE TREATMENT OF MAMMALIAN HIV INFECTION
DE69707680D1 (en) CAPRIN ARTHRITIS-ENZEPHALITIS VIRUS VACCINE CONTAINING AND USE FOR IMMUNE PROTECTION AGAINST HIV-1 INFECTION
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
AP9801368A0 (en) Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection
ATE137968T1 (en) USE OF L-2-OXOTHIAZOLIDINE-4-CARBOXYLATE FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF LATENT HIV INFECTIONS
RU94038588A (en) Method of secondary immunodeficiency treatment
GR3007580T3 (en)
AU6447690A (en) Method of administering soluble t4 for treatment of human immunodeficiency virus infection